(Q40474306)

20 September 2017

title

A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy. (English)

1 reference

20 September 2017

8

1 reference

20 September 2017

Kimberly J Van Zee

6

0 references

Katherine S Panageas

3

object named as

Katherine S Panageas

1 reference

20 September 2017

Michael W Kattan

1

1 reference

20 September 2017

Dilip Giri

2

1 reference

20 September 2017

Amanda Hummer

4

1 reference

20 September 2017

Milicent Cranor

5

1 reference

20 September 2017

Clifford A Hudis

7

1 reference

20 September 2017

Patrick I Borgen

9

1 reference

20 September 2017

Lee K Tan

10

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

20 September 2017

1 reference

20 September 2017

volume

101

1 reference

20 September 2017

issue

11

1 reference

20 September 2017

page(s)

2509-2515

1 reference

Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed?

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Adjuvant therapy for breast cancer: recommendations for management based on consensus review and recent clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Should women with node-negative breast cancer receive adjuvant chemotherapy?--Insights from a decision analysis model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Postoperative nomogram for 12-year sarcoma-specific death

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Histological grading of breast carcinomas: a study of interobserver agreement.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

A competing-risks nomogram for sarcoma-specific death following local recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Evaluating the yield of medical tests

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Women's preferences for discussion of prognosis in early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Quality of life assessment in the adjuvant setting: is it relevant? International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Evaluating a new marker's predictive contribution.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Understanding the utility of adjuvant systemic therapy for primary breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20635

7 January 2021

Identifiers

DOI

10.1002/CNCR.20635

1 reference

20 September 2017

1 reference